<SEC-DOCUMENT>0002044377-26-000002-index.html : 20260518
<SEC-HEADER>0002044377-26-000002.hdr.sgml : 20260518
<ACCEPTANCE-DATETIME>20260518202001
ACCESSION NUMBER:		0002044377-26-000002
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20260518
DATE AS OF CHANGE:		20260518

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Odyssey Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001882782
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				863384382
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-95704
		FILM NUMBER:		26995603

	BUSINESS ADDRESS:	
		STREET 1:		51 SLEEPER STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210
		BUSINESS PHONE:		(212) 841-1000

	MAIL ADDRESS:	
		STREET 1:		51 SLEEPER STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lightspeed Venture Partners XV-B (Ignite), L.P.
		CENTRAL INDEX KEY:			0002044377
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	BUSINESS ADDRESS:	
		STREET 1:		2200 SAND HILL ROAD
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025
		BUSINESS PHONE:		650-234-8300

	MAIL ADDRESS:	
		STREET 1:		2200 SAND HILL ROAD
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex-99-05192026_120500.htm
<DESCRIPTION>JOINT FILING AGREEMENT
<TEXT>
Document 2 - file: ex-99-05192026_120500.htm

</DOCUMENT>
</SEC-DOCUMENT>